The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Cancer-Associated Mutations in Endometriosis without Cancer
Open accessAbstract
BACKGROUND: Endometriosis, defined as the presence of ectopic endometrial stroma and epithelium, affects approximately 10% of reproductive-age women and can cause pelvic pain and infertility. Endometriotic lesions are considered to be benign inflammatory lesions but have cancerlike features such as local invasion and resistance to apoptosis. METHODS: We analyzed deeply infiltrating endometriotic lesions from 27 patients by means of exomewide sequencing (24 patients) or cancer-driver targeted sequencing (3 patients). Mutations were validated with the use of digital genomic methods in microdissected epithelium and stroma. Epithelial and stromal components of lesions from an additional 12 patients were analyzed by means of a droplet digital polymerase-chain-reaction (PCR) assay for recurrent activating KRAS mutations. RESULTS: Exome sequencing revealed somatic mutations in 19 of 24 patients (79%). Five patients harbored known cancer driver mutations in ARID1A, PIK3CA, KRAS, or PPP2R1A, which were validated by Safe-Sequencing System or immunohistochemical analysis. The likelihood of driver genes being affected at this rate in the absence of selection was estimated at P=0.001 (binomial test). Targeted sequencing and a droplet digital PCR assay identified KRAS mutations in 2 of 3 patients and 3 of 12 patients, respectively, with mutations in the epithelium but not the stroma. One patient harbored two different KRAS mutations, c.35G→T and c.35G→C, and another carried identical KRAS c.35G→A mutations in three distinct lesions. CONCLUSIONS: We found that lesions in deep infiltrating endometriosis, which are associated with virtually no risk of malignant transformation, harbor somatic cancer driver mutations. Ten of 39 deep infiltrating lesions (26%) carried driver mutations; all the tested somatic mutations appeared to be confined to the epithelial compartment of endometriotic lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While nucleotide variants or mutations were noted sporadically in the epithelial component of ovarian endometriomas or deep-infiltrating endometriosis, stromal cells consistently lack any somatic mutations (Anglesio et al., 2017).”
From Endometriosis and nuclear receptors (2019) · cites this paper as Anglesio et al., 2017
Experimental — accuracy not yet measuredIn the citing paper
“Recently, molecular biology techniques using a next‐generation sequencing have also provided clues to the origin of endometriosis and pathogenesis that cannot be elucidated by epidemiological investigations alone.”
From Extra-pelvic endometriosis: a review. (2020) · cites this paper as [104]
In the citing paper
“Cancer genomic mutations have also been reported for extraovarian endometriosis in recent years, and mutations in cancer-associated genes, such as PIK3CA, KRAS, and ARID1A, have been identified [106].”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [106]
In the citing paper
“Cancer genomic mutations have also been reported for extraovarian endometriosis in recent years, and mutations in cancer-associated genes, such as PIK3CA, KRAS, and ARID1A, have been identified [106].”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,625
Sampson, J. A. (1927) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30003-x · Cited by 2,334
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq929 · Cited by 2,278
Giudice, L. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1000274 · Cited by 1,924
Bulun, S. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804690 · Cited by 1,772
High burden and pervasive positive selection of somatic mutations in normal human skin
Martincorena, I., Roshan, A., Gerstung, M., Ellis, P., Van Loo, P., McLaren, S., Wedge, D. C., Fullam, A., Alexandrov, L. B., Tubio, J. M., et al. (2015) · Science · doi:10.1126/science.aaa6806 · Cited by 1,770
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712
Self-citationDetection and quantification of rare mutations with massively parallel sequencing
Kinde, I., Wu, J., Papadopoulos, N., Kinzler, K. W., & Vogelstein, B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105422108 · Cited by 1,144
Self-citationSimoens, S., Dunselman, G., Dirksen, C., Hummelshoj, L., Bokor, A., Brandes, I., Brodszky, V., Canis, M., Colombo, G. L., DeLeire, T., et al. (2012) · Human Reproduction · doi:10.1093/humrep/des073 · Cited by 1,070
(1927) · PubMed Central · Cited by 1,008
Flagged first, then by citations
Research works printed but not linked: 4
- Ferguson BR, 1969, Obstet Gynecol, 33, 617
- Sampson JA, 1927, Am J Pathol, 3, 93
- Sato N, 2000, Cancer Res, 60, 7052
- Cullen TS. Adenoma-myoma uteri diffusum benignum. Johns Hopkins Hosp Bull 1896;6:133-7.
Cited by
Sorted by citations
Items 101–200 of 629
Surgical prevention strategies in ovarian cancer
Mallen, A. R., Soong, T. R., Townsend, M. K., Wenham, R. M., Crum, C. P., & Tworoger, S. S. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.08.005 · Cited by 61
Role for Growth Regulation by Estrogen in Breast Cancer 1 (GREB1) in Hormone-Dependent Cancers
Cheng, M., Michalski, S., & Kommagani, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092543 · Cited by 59
Endometriosis-Associated Ovarian Cancer: From Molecular Pathologies to Clinical Relevance
Steinbuch, S. C., Lüß, A.-M., Eltrop, S., Götte, M., & Kiesel, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084306 · Cited by 66
The presence of KRAS, PPP2R1A and ARID1A mutations in 101 Chinese samples with ovarian endometriosis
Zou, Y., Zhou, J., Guo, J.-B., Wang, L., Luo, Y., Zhang, Z., Liu, F., Tan, J., Wang, F., & Huang, O. (2018) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2018.03.001 · Cited by 57
Endometriosis-associated ovarian cancer: What have we learned so far?
Herreros‐Villanueva, M., Chen, C.-C., Tsai, E., & Er, T. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.02.016 · Cited by 59
The paradox of cancer genes in non-malignant conditions: implications for precision medicine
Adashek, J. J., Kato, S., Lippman, S. M., & Kurzrock, R. (2020) · Genome Medicine · doi:10.1186/s13073-020-0714-y · Cited by 59
Malignant Transformation and Associated Biomarkers of Ovarian Endometriosis: A Narrative Review
Михалева, Л. М., Davydov, A. I., Игоревна, П. О., Вячеславовна, М. Е., Nikolenko, V. N., Неганова, М. Е., Klochkov, S. G., Somasundaram, S. G., Kirkland, C. E., & Aliev, G. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01363-5 · Cited by 60
Li, T., Wang, J., Guo, X., Yu, Q., Ding, S., Xu, X., Peng, Y., Zhu, L., Zou, G., & Zhang, X. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110476 · Cited by 58
Deep Dyspareunia: Review of Pathophysiology and Proposed Future Research Priorities
Orr, N. L., Wahl, K., Joannou, A., Hartmann, D., Valle, L., Yong, P. J., International Society for the Study of Women’s Sexual Health’s (ISSWSH) Special Interest Group on Sexual Pain, Babb, C. R., Kramer, C. W., Kellogg‐Spadt, S., et al. (2019) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2018.12.007 · Cited by 59
Self-citationSTRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells
Kim, J. W., Berrios, C. J., Kim, M., Schade, A. E., Adelmant, G., Yeerna, H., Damato, E., Iniguez, A. B., Swanson, S. K., Florens, L. A., et al. (2020) · eLife · doi:10.7554/elife.53003 · Cited by 54
Pelvic endometriosis and natural killer cell immunity
Fukui, A., Mai, C., Saeki, S., Yamamoto, M., Takeyama, R., Kato, T., Ukita, Y., Wakimoto, Y., Yamaya, A., & Shibahara, H. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13342 · Cited by 55
Kennedy, S. R., Zhang, Y., & Risques, R. A. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.07.007 · Cited by 59
Masuda, H., Schwab, K. E., Filby, C. E., Tan, C., Tsaltas, J., Weston, G. C., & Gargett, C. E. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.04.008 · Cited by 58
Spatiotemporal dynamics of clonal selection and diversification in normal endometrial epithelium
Yamaguchi, M., Nakaoka, H., Suda, K., Yoshihara, K., Ishiguro, T., Yachida, N., Saito, K., Ueda, H., Sugino, K., Mori, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28568-2 · Cited by 54
Clonal lineage from normal endometrium to ovarian clear cell carcinoma through ovarian endometriosis
Suda, K., Diaz, L. A. C., Yoshihara, K., Nakaoka, H., Yachida, N., Motoyama, T., Inoue, I., & Enomoto, T. (2020) · Cancer Science · doi:10.1111/cas.14507 · Cited by 53
Self-citationBronkhorst, A. J., Ungerer, V., & Holdenrieder, S. (2019) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2019.1700902 · Cited by 56
The Endometriotic Tumor Microenvironment in Ovarian Cancer
Wendel, J. R. H., Wang, X., & Hawkins, S. M. (2018) · Cancers · doi:10.3390/cancers10080261 · Cited by 51
Clear cell carcinomas of the ovary and kidney: clarity through genomics
Ji, J. X. Y., Wang, Y. K., Cochrane, D. R., & Huntsman, D. D. (2018) · The Journal of Pathology · doi:10.1002/path.5037 · Cited by 52
Self-citationEndometriosis and autoimmunity
Blanco, L. P., Salmeri, N., Temkin, S. M., Shanmugam, V. K., & Stratton, P. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103752 · Cited by 59
Should genetics now be considered the pre-eminent etiologic factor in endometriosis?
Montgomery, G. W., Mortlock, S., & Giudice, L. C. (2020) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2019.10.020 · Cited by 49
Evidence in Support for the Progressive Nature of Ovarian Endometriomas
Ding, D., Wang, X., Chen, Y.-S., Benagiano, G., Liu, X., & Guo, S. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa189 · Cited by 49
Fetal-Derived Immune Cells at the Roots of Lifelong Pathophysiology
Mass, E., & Gentek, R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.648313 · Cited by 47
Genetic variation across and within individuals
Yu, Z., Coorens, T. H. H., Uddin, M. M., Ardlie, K., Lennon, N. J., & Natarajan, P. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-024-00709-x · Cited by 51
Papadopoulos, N. (2019) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-030-26439-0_9 · Cited by 49
Self-citationEpigenetic Factors in Eutopic Endometrium in Women with Endometriosis and Infertility
Adamczyk, M., Wender-Ożegowska, E., & Kędzia, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073804 · Cited by 51
SWI/SNF Complexes in Ovarian Cancer: Mechanistic Insights and Therapeutic Implications
Fukumoto, T., Magno, E., & Zhang, R. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0368 · Cited by 47
Treatment Strategies for ARID1A-Deficient Ovarian Clear Cell Carcinoma
Takahashi, K., Takenaka, M., Okamoto, A., Bowtell, D. D. L., & Kohno, T. (2021) · Cancers · doi:10.3390/cancers13081769 · Cited by 47
Endometriosis caused by retrograde menstruation: Now demonstrated by DNA evidence
Bulun, S. E. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.07.012 · Cited by 46
Metabolomics in endometriosis: challenges and perspectives for future studies
Ortiz, C. N., Torres-Reverón, A., & Appleyard, C. B. (2021) · Reproduction and Fertility · doi:10.1530/raf-20-0047 · Cited by 50
Yıldız, Ş., Kinali, M., Wei, J., Milad, M. P., Yin, P., Adli, M., & Bulun, S. E. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.01.041 · Cited by 46
Yeh, C., Su, F., Tzeng, C., Muo, C., & Wang, W. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194011 · Cited by 46
A Review of the Clinical Characteristics and Novel Molecular Subtypes of Endometrioid Ovarian Cancer
Chen, S., Li, Y., Qian, L., Deng, S., Liu, L., Xiao, W., & Zhou, Y. Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.668151 · Cited by 47
A Revised Stem Cell Theory for the Pathogenesis of Endometriosis
Maruyama, T. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020216 · Cited by 49
Liu, S., Li, X., Gu, Z., Wu, J., Jia, S., Shi, J., Dai, Y. L., Wu, Y., Yan, H., Zhang, J., et al. (2025) · Cell Genomics · doi:10.1016/j.xgen.2024.100737 · Cited by 51
Vercellini, P., Bandini, V., Viganò, P., Ambruoso, D., Cetera, G. E., & Somigliana, E. (2023) · Human Reproduction · doi:10.1093/humrep/dead206 · Cited by 45
García-Solares, J., Dolmans, M., Squifflet, J.-L., Donnez, J., & Donnez, O. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.08.016 · Cited by 44
Yachida, N., Yoshihara, K., Yamaguchi, M., Suda, K., Tamura, R., & Enomoto, T. (2021) · Cancers · doi:10.3390/cancers13061439 · Cited by 48
Ectopic Endometrium: The Pathologist’s Perspective
Camboni, A., & Marbaix, É. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010974 · Cited by 46
Praetorius, T. H., Leonova, A., Lac, V., Senz, J., Tessier-Cloutier, B., Nazeran, T. M., Köbel, M., Grube, M., Kraemer, B., Yong, P. J., et al. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.05.030 · Cited by 43
Self-citationWang, M., Wu, Y., He, Y., Liu, J., Chen, Y., Huang, J., Qi, G., & Li, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-16629-x · Cited by 43
Preneoplastic somatic mutations including MYD88 L265P in lymphoplasmacytic lymphoma
Rodríguez, S., Celay, J., Goicoechea, I., Jiménez, C., Botta, C., Garcia-Barchino, M. J., Garcés, J., Larráyoz, M., Santos, S. A., Alignani, D., et al. (2022) · Science Advances · doi:10.1126/sciadv.abl4644 · Cited by 47
Clonal haematopoiesis, ageing and kidney disease
Vlasschaert, C., Lanktree, M. B., Rauh, M. J., Kelly, T. N., & Natarajan, P. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00778-x · Cited by 42
Somatic variation in normal tissues: friend or foe of cancer early detection?
Acha‐Sagredo, A., Ganguli, P., & Ciccarelli, F. D. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.09.156 · Cited by 41
Shin, S. Y., Chung, Y., Moon, S. W., Choi, E. J., Kim, J.-H., Chung, Y., & Lee, S. H. (2023) · The Journal of Pathology · doi:10.1002/path.6178 · Cited by 42
Yen, T., Miyamoto, T., Asaka, S., Chui, M. H., Wang, Y., Lin, S., Stone, R. L., Fader, A. N., Asaka, R., Kashima, H., et al. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.06.025 · Cited by 42
Self-citationGomolka, M., Blyth, B. J., Bourguignon, M., Badie, C., Schmitz, A., Talbot, C. J., Hoeschen, C., & Salomaa, S. I. (2019) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1642544 · Cited by 42
Mutations in normal tissues—some diagnostic and clinical implications
Fiala, C., & Diamandis, E. P. (2020) · BMC Medicine · doi:10.1186/s12916-020-01763-y · Cited by 42
miR-205-5p inhibits human endometriosis progression by targeting ANGPT2 in endometrial stromal cells
Zhou, C.-F., Liu, M.-J., Wang, W., Wu, S., Huang, Y., Chen, G.-B., Liu, L.-M., Peng, D., Wang, X., Cai, X., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1388-5 · Cited by 40
Cellular Origins of Endometriosis: Towards Novel Diagnostics and Therapeutics
Filby, C. E., Rombauts, L. J. F., Montgomery, G. W., Giudice, L. C., & Gargett, C. E. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0040-1713429 · Cited by 40
A Call for New Theories on the Pathogenesis and Pathophysiology of Endometriosis
Canis, M. J., Abbott, J. A., Abrão, M. S., Al‐Jefout, M., Bedaiwy, M. A., Benagiano, G., Burns, K. A., Canis, M. J., Carmona, F., Chapron, C., et al. (2024) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2024.02.004 · Cited by 39
Self-citationTaylor, H. S., Dun, E. C., & Chwalisz, K. (2019) · Pain Management · doi:10.2217/pmt-2019-0010 · Cited by 38
Somatic Mutation: What Shapes the Mutational Landscape of Normal Epithelia?
Fowler, J. C., & Jones, P. H. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0145 · Cited by 41
Rethinking of treatment strategies and clinical management in ovarian clear cell carcinoma
Takahashi, K., Takenaka, M., Kawabata, A., Yanaihara, N., & Okamoto, A. (2020) · International Journal of Clinical Oncology · doi:10.1007/s10147-020-01625-w · Cited by 38
Xing, D., Zheng, G., Pallavajjala, A., Schoolmeester, J. K., Liu, Y., Haley, L. M., Hu, Y., Liu, L., Logan, L., Lin, Y., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-4278 · Cited by 38
The role of regulatory T-cells in the development of endometriosis
Knez, J., Kovačič, B., & Goropevšek, A. (2024) · Human Reproduction · doi:10.1093/humrep/deae103 · Cited by 36
Current Knowledge on Endometriosis Etiology: A Systematic Review of Literature
Михалева, Л. М., Radzinsky, V. E., Orazov, M. R., Николаевна, Х. Т., Sorokina, A. V., Александрович, М. С., Владимировна, В. С., Shustova, V. B., & Sinelnikov, M. Y. (2021) · International Journal of Women s Health · doi:10.2147/ijwh.s306135 · Cited by 37
Kiisholts, K., Kurrikoff, K., Arukuusk, P., Porosk, L., Peters, M., Salumets, A., & Langel, Ü. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101618 · Cited by 36
Therapeutic preferability of gemcitabine for ARID1A-deficient ovarian clear cell carcinoma
Kuroda, T., Ogiwara, H., Sasaki, M., Takahashi, K., Yoshida, H., Kiyokawa, T., Sudo, K., Tamura, K., Kato, T., Okamoto, A., et al. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.10.002 · Cited by 35
KRAS mutations and endometriosis burden of disease
Orr, N. L., Albert, A., Liu, Y. D., Lum, A. M., Hong, J., Ionescu, C. L., Senz, J., Nazeran, T. M., Lee, A. F., Noga, H. L., et al. (2023) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.317 · Cited by 37
Self-citationOvarian Cancer: From Precursor Lesion Identification to Population-Based Prevention Programs
Sowamber, R., Lukey, A., Huntsman, D. D., & Hanley, G. E. (2023) · Current Oncology · doi:10.3390/curroncol30120741 · Cited by 34
Self-citationLiu, H., Zhang, W., Wang, L., Zhang, Z., Xiong, W., Zhang, L., Fu, T., Li, X., Chen, Y., & Liu, Y. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.10.76 · Cited by 33
Yachida, N., Yoshihara, K., Suda, K., Nakaoka, H., Ueda, H., Sugino, K., Yamaguchi, M., Mori, Y., Yamawaki, K., Tamura, R., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-71273-7 · Cited by 33
Marquardt, R. M., Kim, T. H., Yoo, J., Teasley, H. E., Fazleabas, A. T., Young, S. L., Lessey, B. A., Arora, R., & Jeong, J. (2020) · The FASEB Journal · doi:10.1096/fj.202002178r · Cited by 32
Prospective Cohort of Deep Dyspareunia in an Interdisciplinary Setting
Yong, P. J., Williams, C., Bodmer-Roy, S., Ezeigwe, C., Zhu, S., Arion, K., Ambacher, K., Yosef, A. H., Wong, F., Noga, H. L., et al. (2018) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2018.10.005 · Cited by 32
Self-citationPathogenesis of bowel endometriosis
Yong, P. J., Bedaiwy, M. A., Alotaibi, F. T., & Anglesio, M. S. (2020) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2020.05.009 · Cited by 35
Self-citationDetection and Diagnostic Utilization of Cellular and Cell-Free Tumor DNA
Dudley, J. C., & Diehn, M. (2020) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032604 · Cited by 31
Gao, S., Nelson, J., Weinsheimer, S., Winkler, E. A., Rutledge, C., Abla, A. A., Gupta, N., Shieh, J. T. C., Cooke, D. L., Hetts, S. W., et al. (2021) · Journal of neurosurgery · doi:10.3171/2020.11.jns202031 · Cited by 32
Vassard, D., Schmidt, L., Glazer, C. H., Forman, J. L., Kamper‐Jørgensen, M., & Pinborg, A. B. (2019) · Human Reproduction · doi:10.1093/humrep/dez165 · Cited by 32
Therapeutic targeting of mismatch repair-deficient cancers
Johannet, P. M., Rousseau, B., Aghajanian, C. A., Foote, M. B., & Diaz, L. A. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01054-6 · Cited by 35
Self-citationA mouse model of endometriosis mimicking the natural spread of invasive endometrium
Wilson, M. R., Holladay, J., & Chandler, R. L. (2019) · Human Reproduction · doi:10.1093/humrep/dez253 · Cited by 30
Cancer‐associated mutations in normal human endometrium: Surprise or expected?
Kyo, S., Sato, S., & Nakayama, K. (2020) · Cancer Science · doi:10.1111/cas.14571 · Cited by 31
Biological significance of KRAS mutant allele expression in ovarian endometriosis
Yachida, N., Yoshihara, K., Suda, K., Nakaoka, H., Ueda, H., Sugino, K., Yamaguchi, M., Mori, Y., Yamawaki, K., Tamura, R., et al. (2021) · Cancer Science · doi:10.1111/cas.14871 · Cited by 32
Beddows, I., Fan, H., Heinze, K., Johnson, B. K., Leonova, A., Senz, J., Djirackor, S., Cho, K. R., Pearce, C. L., Huntsman, D. D., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-1362 · Cited by 29
Self-citationOncogenic BRAF and KRAS mutations in endosalpingiosis
Chui, M. H., & Shih, I. (2019) · The Journal of Pathology · doi:10.1002/path.5353 · Cited by 30
Self-citationDisturbed progesterone signalling in an advanced preclinical model of endometriosis
Esfandiari, F., Khoei, H. H., Saber, M., Favaedi, R., Piryaei, A., Moini, A., Shahhoseini, M., Ramezanali, F., Ghaffari, F., & Baharvand, H. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.12.011 · Cited by 30
A Systematic Review of Atypical Endometriosis-Associated Biomarkers
Bartiromo, L., Schimberni, M., Villanacci, R., Mangili, G., Ferrari, S. M., Ottolina, J., Salmeri, N., Dolci, C., Tandoi, I., & Candiani, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084425 · Cited by 33
Diet associations in endometriosis: a critical narrative assessment with special reference to gluten
Brouns, F. J. P. H., van Haaps, A. P., Keszthelyi, D., Venema, K., Bongers, M. Y., Maas, J. W. M., & Mijatovic, V. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1166929 · Cited by 39
Ovarian cancer in adolescents and young adults
Lockley, M., Stoneham, S. J., & Olson, T. A. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27512 · Cited by 30
Long-Term Health Consequences of Endometriosis—Pathways and Mediation by Treatment
Farland, L. V., & Harris, H. R. (2020) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-020-00287-9 · Cited by 32
Epigenome Chaos: Stochastic and Deterministic DNA Methylation Events Drive Cancer Evolution
Russo, G., Tramontano, A., Iodice, I., Chiariotti, L., & Pezone, A. (2021) · Cancers · doi:10.3390/cancers13081800 · Cited by 30
Matsuzaki, S., Nagase, Y., Ueda, Y., Kakuda, M., Maeda, M., Matsuzaki, S., & Kamiura, S. (2021) · Biomedicines · doi:10.3390/biomedicines9111536 · Cited by 31
New Evidence About Malignant Transformation of Endometriosis—A Systematic Review
Ioannidou, A., Sakellariou, M., Sarli, V. G., Panagopoulos, P., & Machairiotis, N. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14092975 · Cited by 31
Understanding Endometriosis: A Broad Review of Its Causes, Management, and Impact
Czubak, P., Herda, K., Niewiadomska, I., Putowski, L. T., Łańcut, M., & Masłyk, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188878 · Cited by 36
He, R., Liu, X., Zhang, J., Wang, Z., Wang, W., Fu, L., Fan, Y., Sun, S., Cao, Y., Zhan, L., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01281 · Cited by 29
Park, Y., Jung, J.-G., Yu, Z.-C., Asaka, R., Shen, W., Wang, Y., Jung, W., Tomaszewski, A., Shimberg, G., Chen, Y., et al. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00624-3 · Cited by 28
Self-citationGuo, S., Habiba, M. A., & Benagiano, G. (2023) · Biomolecules · doi:10.3390/biom13020336 · Cited by 30
Endometriosis: benign, malignant, or something in between?
Chui, M. H., Wang, T., & Shih, I. (2017) · Oncotarget · doi:10.18632/oncotarget.21051 · Cited by 28
Self-citationEpithelial Cells of Deep Infiltrating Endometriosis Harbor Mutations in Cancer Driver Genes
Koppolu, A. A., Maksym, R., Paskal, W., Machnicki, M. M., Rak, B., Pępek, M., Garbicz, F., Pełka, K., Kuśmierczyk, Z., Jacko, J., et al. (2021) · Cells · doi:10.3390/cells10040749 · Cited by 28
Origins based clinical and molecular complexities of epithelial ovarian cancer
Muinao, T., Pal, M., & Boruah, H. P. D. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.06.036 · Cited by 29
Tetraspanin 1 promotes endometriosis leading to ovarian clear cell carcinoma
Shin, H., Yang, W., Chay, D. B., Lee, E., Chung, J., Kim, H., & Kim, J. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12884 · Cited by 27
Endometriosis and ovulatory menstruation: beyond the Sampson principle
Bulun, S. E. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188787 · Cited by 29
Endometrial Cancer Incidence in Endometriosis and Adenomyosis
Hermens, M., van Altena, A. M., Velthuis, I., van de Laar, D. C. M., Bulten, J., van Vliet, H. A. A. M., Siebers, A. G., & Bekkers, R. L. M. (2021) · Cancers · doi:10.3390/cancers13184592 · Cited by 26
Treatment of ovarian clear cell carcinoma with immune checkpoint blockade: a case series
Sia, T., Manning‐Geist, B. L., Gordhandas, S., Murali, R., Marra, A., Liu, Y. L., Friedman, C. F., Hollmann, T. J., Zivanovic, O., Dennis, S., et al. (2022) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2022-003430 · Cited by 26
Somatic mutations and T-cell clonality in patients with immunodeficiency
Savola, P., Martelius, T., Kankainen, M., Huuhtanen, J., Lundgren, S., Koski, Y., Eldfors, S., Kelkka, T., Keränen, M. A. I., Ellonen, P., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.220889 · Cited by 25
Nezhat, C. R., Oskotsky, T. T., Robinson, J. F., Fisher, S. J., Tsuei, A., Liu, B., Irwin, J. C., Gaudilliere, B., Sirota, M., Stevenson, D. K., et al. (2025) · npj Women s Health · doi:10.1038/s44294-024-00052-w · Cited by 25
Wang, S., Zhang, M., Zhang, T., Deng, J., Xia, X., & Fang, X. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-019-05429-w · Cited by 25
Self-citationAcquired Evolution of Mitochondrial Metabolism Regulated by HNF1B in Ovarian Clear Cell Carcinoma
Yamaguchi, K. D., Kitamura, S., Furutake, Y., Murakami, R., Yamanoi, K., Taki, M., Ukita, M., Hamanishi, J., & Mandai, M. (2021) · Cancers · doi:10.3390/cancers13102413 · Cited by 26
Cemento-osseous dysplasia is caused by RAS-MAPK activation
Haefliger, S., Turek, D., Andrei, V., Alborelli, I., Calgua, B., Ameline, B., Harder, D., & Baumhoer, D. (2022) · Pathology · doi:10.1016/j.pathol.2022.10.006 · Cited by 25
Epithelial Cells in Endometriosis and Adenomyosis Upregulate STING Expression
Qu, H., Li, L., Wang, T., Seckin, T. A., Segars, J. H., & Shih, I. (2020) · Reproductive Sciences · doi:10.1007/s43032-019-00127-z · Cited by 25
Self-citationKobayashi, H., Imanaka, S., Yoshimoto, C., Matsubara, S., & Shigetomi, H. (2024) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.16089 · Cited by 26
Metadata
- Authors
- Anglesio, M. S., Papadopoulos, N., Ayhan, A., Nazeran, T. M., Noë, M., Horlings, H. M., Lum, A., Jones, S., Senz, J., Seckin, T., Ho, J., Wu, R.-C., Lac, V., Ogawa, H., Tessier-Cloutier, B., Alhassan, R., Wang, A., Wang, Y., Cohen, J. D., Wong, F., Hasanovic, A., Orr, N., Zhang, M., Popoli, M., McMahon, W., Wood, L. D., Mattox, A., Allaire, C., Segars, J., Williams, C., Tomasetti, C., Boyd, N., Kinzler, K. W., Gilks, C. B., Diaz, L., Wang, T.-L., Vogelstein, B., Yong, P. J., Huntsman, D. G., & Shih, I.-M.
- Affiliations
- University of British Columbia (CA)
- Hiroshima University (JP)
- BC Cancer Agency (CA)
- Howard Hughes Medical Institute (US)
- ORCID
- Anglesio, Michael S.
- Papadopoulos, Nickolas
- Ayhan, Ayse
- Noë, Michaël
- Horlings, Hugo M.
- Lum, Amy
- Jones, Siân
- Senz, Janine
- Seckin, Tamer
- Wu, Ren-Chin
- Lac, Vivian
- Ogawa, Hiroshi
- Wang, Yuxuan
- Cohen, Joshua D.
- Orr, Natasha
- Zhang, Ming
- Popoli, Maria
- Wood, Laura D.
- Mattox, Austin
- Allaire, Catherine
- Segars, James
- Tomasetti, Cristian
- Boyd, Niki
- Kinzler, Kenneth W.
- Gilks, C. Blake
- Diaz, Luis
- Wang, Tian-Li
- Vogelstein, Bert
- Yong, Paul J.
- Shih, Ie-Ming
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-05-11
- Volume
- 376
- Issue
- 19
- Pages
- 1835-1848
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC5555376
- OpenAlex
- W2612851374
- Cited by
- 628
- References
- 50
- Citations by year
- 2026: 57 · 2025: 62 · 2024: 51 · 2023: 75 · 2022: 72 · 2021: 75 · 2020: 80 · 2019: 68 · 2018: 69 · 2017: 19
- FWCI
- 74.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA215483, U01CA200469, R01CA057345, T32CA009243, P50CA062924, R37CA057345, P30CA006973)
- National Institute of General Medical Sciences (T32GM007309, T32GM007184)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- endometriosis, deep infiltrating endometriosis, somatic mutations, cancer driver mutations, KRAS mutation, ARID1A, PIK3CA, PPP2R1A, malignant transformation risk, droplet digital PCR
- MeSH terms
- Adult, Cell Transformation, Neoplastic, DNA Mutational Analysis, DNA-Binding Proteins, Endometriosis, Endometrium, Female, Humans, Middle Aged, Mutation, Nuclear Proteins, Transcription Factors, Polymerase Chain Reaction, Proto-Oncogene Proteins p21(ras), Phosphatidylinositol 3-Kinases, Protein Phosphatase 2, Class I Phosphatidylinositol 3-Kinases, Exome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
